Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FluINsure delivers strong immunogenicity data in phase II trials

June 23, 2003

FDA approves FluMist as first intranasal influenza vaccine

June 19, 2003

Enzon acquires North American license to ATG-Fresenius S

June 19, 2003

New cathepsin S inhibitors described by Aventis and AxyS (Celera Genomics)

June 16, 2003

Stronger potency reported for ISA-247 vs. ciclosporin in renal transplant patients

June 13, 2003

Avant awarded two new subcontracts for oral anthrax and plague vaccines

June 13, 2003

Src kinase inhibitor protects mouse heart allografts

June 12, 2003

Final phase IIa results from kidney transplant study of ISA-247

June 11, 2003

BioSante signs biodefense vaccine CRADA with U.S. Army

June 11, 2003

Pfizer presents promising preclinical data for CP-690550

June 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...